Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Marta Lemieszewska, Agnieszka Tarnowska, Helena Pakos, Anna Sobczynska-Konefal, Andrzej Lange, MD

Blood (2019) 134 (Supplement_1): 5164.

https://doi.org/10.1182/blood-2019-130316

Published: 2019

Journal Articles

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Emilia Jaskula, Andrzej Lange, MD, Mariola Sedzimirska, Jakub Chrustowicz, Agnieszka Tarnowska, Janusz Lange

Blood (2017) 130 (Supplement 1): 1420.

https://doi.org/10.1182/blood.V130.Suppl_1.1420.1420

Published: 2017

Journal Articles

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Mariola Sedzimirska, MD PhD, Andrzej Lange, MD Dr MDSci., Professor

Blood (2014) 124 (21): 5265.

https://doi.org/10.1182/blood.V124.21.5265.5265

Published: 2014

Journal Articles

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

Andrzej Lange, MD, DSci, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Przemyslaw Czajka, MSci, Janusz Lange, MD, Monika Mordak, MD, Dorota Dlubek, PhD

Blood (2012) 120 (21): 4487.

https://doi.org/10.1182/blood.V120.21.4487.4487

Published: 2012

Journal Articles

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

Andrzej Lange, MD, DSci, Emilia Jaskula, PhD, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Janusz Lange, MD

Blood (2011) 118 (21): 4552.

https://doi.org/10.1182/blood.V118.21.4552.4552

Published: 2011

Journal Articles

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Janusz Lange, MD, Daria Drabczak-Skrzypek, Dorota Dlubek, Emilia Jaskula, Dariusz Wolowiec, Andrzej Lange, MD

Blood (2010) 116 (21): 4555.

https://doi.org/10.1182/blood.V116.21.4555.4555

Published: 2010

Journal Articles

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Andrzej Lange, MD, PhD, Dorota Dlubek, PhD, Emilia Jaskula, Daria Drabczak-Skrzypek, Mariola Sedzimirska, MD, PhD, Janusz Lange, MD

Blood (2008) 112 (11): 2226.

https://doi.org/10.1182/blood.V112.11.2226.2226

Published: 2008

Journal Articles

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

Andrzej Lange, Dorota Dlubek, PhD, Mariola Sedzimirska, Dr.med.Sci, Daria Drabczak-Skrzypek, MSci, Emilia Jaskula, MSci, Janusz Lange, MD

Blood (2007) 110 (11): 4971.

https://doi.org/10.1182/blood.V110.11.4971.4971

Published: 2007

Journal Articles

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Brie E. Turner, BSc (Hons), Melinda E. Kambouris, BSc(Hons), Janusz Lange, MD, Kerry Atkinson, MBBS, MD, Derek N. Hart, MBBS, DPhil, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2006) 108 (11): 3218.

https://doi.org/10.1182/blood.V108.11.3218.3218

Published: 2006

Journal Articles

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Brie E. Turner, BSc (Hons), Melinda Christensen, B.Sc, Janusz Lange, MBBS, Ann-Marie Burns, Derek N.J. Hart, MBBS, D. Phil, Kerry Atkinson, MBBS, MD, David J. Munster, PhD, Alison M. Rice, PhD

Blood (2005) 106 (11): 3112.

https://doi.org/10.1182/blood.V106.11.3112.3112

Published: 2005

NARROW

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Increase in Proportion of Th-17 Lymphocytes in Blood Heralds Overt Acute Graft Versus Host Disease in HSCT Patients.

Increased Interleukin-17 Proportion in Helper T Cell (Th17) in Patients Post Allogeneic Hematopoietic Stem Cell Transplantation.

Delayed Onset GVHD Following Reduced Intensity Conditioning HSCT Is Associated with Persisting Host DC and Late Emergence of Activated Donor DC.

Conditioning Intensity and Dendritic Cell (DC) Activation: Implications for GVHD Control Using DC Depleting Antibodies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only